Transcriptomics

Dataset Information

3

Further Insights into the Mode of Action of the Lipoglycopeptide Telavancin through Global Gene Expression Studies


ABSTRACT: Background: Telavancin is a novel semi-synthetic lipoglycopeptide derivative of vancomycin with a decylaminoethyl side chain that is active against Gram-positive bacteria including Staphylococcus aureus strains resistant to methicillin or vancomycin. This study describes transcriptome alterations in S. aureus strain ATCC29213 treated with telavancin for 15 min and 60 min in comparing with other agents treatment, including vancomycin, enduracidin, m-chlorophenylhydrazone. MHB cultures (biological replicates: N=3) were then grown to exponential phase (OD580=0.35) before the addition of telavancin(8 µg/ml final concentration), or vancomycin (10 /µg ml) or CCCP (2 µg/ ml ); or enduracidin (1 µg ml) and incubated for an additional 15 min , and 60 min before sampling. Dye-swapping was performed between samples.

ORGANISM(S): Staphylococcus aureus  

SUBMITTER: Yang Song   Arunachalam Muthaiyan 

PROVIDER: E-GEOD-37272 | ArrayExpress | 2012-04-13

SECONDARY ACCESSION(S): GSE37272PRJNA159219

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

2016-03-30 | E-GEOD-79687 | ArrayExpress
2010-11-25 | E-MEXP-1947 | ArrayExpress
2010-06-10 | E-GEOD-8135 | ArrayExpress
2008-08-08 | GSE12364 | GEO
2012-01-01 | E-GEOD-31911 | ArrayExpress
2010-03-02 | E-MEXP-2436 | ArrayExpress
2011-11-24 | E-GEOD-33909 | ArrayExpress
2014-03-31 | E-GEOD-50826 | ArrayExpress
2011-04-29 | E-MEXP-3032 | ArrayExpress
2014-07-30 | E-GEOD-58176 | ArrayExpress